Ab Therapeutics


Ab Therapeutics Inc. develops next generation multi-specific therapeutic antibodies with balanced safety, efficacy, and developability for the treatment of cancers and other difficult-to-treat diseases. We license Ab Studio’s (www.antibodystudio.com) unique technology platform and incorporate Genor Biopharma’s unique CMC and clinical development experience to develop novel therapeutic antibodies.

Company Information

March 16, 2022